Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial

BACKGROUND: Sudden sensorineural hearing loss (SSHL) is a common condition in which patients lose the hearing in one ear within 3 days. Systemic glucocorticoid treatments have been used as standard therapy for SSHL; however, about 20% of patients do not respond. We tested the safety and efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Takayuki, Sakamoto, Tatsunori, Hiraumi, Harukazu, Kikkawa, Yayoi S, Yamamoto, Norio, Hamaguchi, Kiyomi, Ono, Kazuya, Yamamoto, Masaya, Tabata, Yasuhiko, Teramukai, Satoshi, Tanaka, Shiro, Tada, Harue, Onodera, Rie, Yonezawa, Atsushi, Inui, Ken-ichi, Ito, Juichi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000370/
https://www.ncbi.nlm.nih.gov/pubmed/21108784
http://dx.doi.org/10.1186/1741-7015-8-76

Ejemplares similares

Ejemplares similares